RESMED INC — Director's Dealing 2011

May 31, 2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity ResMed Inc. (RMD) ABN 46 064 514 852

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Christopher Roberts
Date of last notice	March 2, 2011

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Direct or indirect interest	Direct or indirect interest	Direct and Indirect	Direct and Indirect	Direct and Indirect
	Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.		Indirect interest includes shares held byChristopher Roberts’ wife; includesshareholdings in Cabbit Pty Ltd and AceMedPty Ltd., 2 Australian corporations owned byChristopher Roberts and his wife;
	Date of change		May 27, 2011 (equivalent to US datedtransaction of May 26, 2011 on the NYSE)
	No. of securities held prior to chan	ge	336,390 optio342,400 shar	ns/Christopher Roberts;es/Cabbit Pty; 23,200	d Pty
			shares/spousLtd	e; 136,000 shares/Aceme
	Class		Common Sto	ck
	Number acquired
	Number disposed		40,000 shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	US$1,278,600
No. of securities held after change	336,390 options/Christopher Roberts;302,400 shares/Cabbit Pty; 23,200shares/spouse; 136,000 shares/Acemed PtyLtd
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	On-market sale

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation
Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts No. detailed above traded during a[+] closed period where prior written clearance was required?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance provided to allow N/A the trade to proceed during this period? If prior written clearance was provided, on what N/A date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3